On Monday, Valeant Pharmaceuticals International named Joseph Para the former CEO at Perrigo Co as its new CEO to work on turning the company around. Doubts over Valeant’s acquisitive model and a controversy over its relationship with a specialty pharmacy have done great damage to the market value of the drug maker. Valeant will restate […]